Almost half (42%) of patients with skin disease experience sleep disturbances, a major study presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2023 has revealed.

The ALL PROJECT, a comprehensive international research initiative, analysed over 50,000 adults across 20 countries to assess the impact of skin diseases. Notably, these sleep disturbances were found to have broader implications on patients’ quality of life. Nearly half (49%) of patients with skin disease reported reduced productivity at work, in contrast with just one in five (19%) participants without a skin disease.

The main symptoms that impacted the sleep of patients with skin disease were itching (60%) and burning sensations or tingling (17%).

Read more